Ellen Wing

Ellen Wing is a goal-oriented professional in the biotech and medical devices sectors, currently serving as the Sr. Director of Contract and Vendor Management at Eli Lilly and Company since 2021. They have a wealth of experience in negotiating and managing contracts, having successfully overseen over 100 clinical study agreements at organizations such as Seaside Therapeutics and Prevail Therapeutics. Ellen's previous roles include Manager of Contracts and Intellectual Property at Coley Pharmaceutical Group and Sr. Contract Administrator at Boston Scientific Corporation, where they focused on compliance, negotiation, and strategic alignment of agreements. Their expertise is complemented by strong leadership skills and the ability to resolve complex business challenges effectively.